Giant Cell Arteritis
📧 Sign up to get email alerts when something new happens for Giant Cell Arteritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.
This clinical trial update describes the VGR GCA Cohort, evaluating ultrasound, biopsy, and biomarkers as novel methods for diagnosing, moni…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis [Phase 2]
Phase 2 clinical trial evaluating discontinuation versus dose reduction of tocilizumab in well-controlled giant cell arteritis is currently …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA
This clinical trial update describes early changes in optic nerve sheath diameter after therapy in giant cell arteritis, with the study curr…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NIAMS sponsors a clinical trial to study the natural history, pathogenesis, and outcomes of idiopathic systemic vasculitis, with recruiting …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
This clinical trial investigates whether ultrasonographic temporal artery lesions are associated with relapse in patients with giant cell ar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency [Phase 4]
Phase 4 clinical trial evaluating supplemental hydrocortisone during stress in patients with prednisolone-induced adrenal insufficiency; cur…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases [Phase 1, Phase 2]
This clinical trial update reports ongoing Phase 1/2 studies evaluating the Ga-68-labeled NI-FAPI-04 PET/CT imaging agent for fibroblast act…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica
This clinical trial update describes a study funded by Hôpital NOVO investigating the association between sacroiliitis/axial spondyloarthrit…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Abatacept for the Treatment of Giant Cell Arteritis [Phase 3]
Ongoing Phase 3 clinical trial evaluating abatacept for giant cell arteritis; currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: VCRC Tissue Repository
The University of Pennsylvania–sponsored VCRC Tissue Repository trial is currently recruiting. It covers multiple forms of vasculitis.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.
A clinical trial is evaluating upadacitinib for Giant Cell Arteritis with active large-vessel involvement (NCT07354906), sponsored by Groupe…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) [Phase 2]
Phase 2 clinical trial DERAIL-LVV is evaluating the combination of dapagliflozin with endothelin receptor antagonism for large vessel vascul…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Impact of the Spatial Resolution of Several Contrast-enhanced 3D T1-WI Sequences When Diagnosing Giant Cell Arteritis (GCA)
This clinical trial update examines how the spatial resolution of contrast-enhanced 3D T1-weighted MRI sequences affects the diagnosis of gi…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment [Phase 4]
Phase 4 clinical trial evaluating hydrocortisone versus placebo in patients with symptoms of adrenal insufficiency after stopping glucocorti…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Giant Cell Arteritis - Ways to Precision Medicine
A recruiting clinical trial at Würzburg University Hospital explores precision medicine approaches for Giant Cell Arteritis and Polymyalgia …
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)
A clinical trial update describing RituxiMAP GCA, a study to map B-cell biology in Giant Cell Arteritis to identify a new therapeutic approa…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
This clinical trial update describes an ongoing study aimed at improving diagnostics and monitoring for Polymyalgia Rheumatica, with Giant C…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
Sponsored by the University of Pennsylvania, the VEGA trial evaluates vascular MRI approaches in Giant Cell Arteritis. The study is currentl…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound [NA]
A clinical trial evaluating optic nerve sheath evaluation in giant cell arteritis using ultrasound is currently recruiting at Hôpital NOVO.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
A pilot clinical study (THROPIQ) is evaluating whether thrombomodulin can help rule out giant cell arteritis in patients with polymyalgia rh…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
This clinical trial update describes ongoing research in safety and efficacy assessment for rheumatologic diseases and related conditions, w…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: The Applanation Tonometry in GCA Pilot
This clinical trial update describes a pilot study evaluating applanation tonometry in Giant Cell Arteritis, currently active but not recrui…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Optic Nerve Sheath Ultrasound in Giant Cell Arteritis
A clinical trial is currently recruiting to evaluate the use of optic nerve sheath ultrasound in patients with giant cell arteritis and rela…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement [Phase 3]
Phase 3 clinical trial evaluating tocilizumab with steroids for giant cell arteritis with cerebrovascular involvement; the study status is c…